Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorReyes Garau, Diana
dc.contributor.authorRibeiro Lima, Marcelo
dc.contributor.authorRoue, Gael
dc.date.accessioned2020-07-31T12:45:56Z
dc.date.available2020-07-31T12:45:56Z
dc.date.issued2019-10-02
dc.identifier.citationReyes-Garau D, Ribeiro M, Roué G. Pharmacological targeting of BET bromodomain proteins in acute myeloid leukemia and malignant lymphomas: from molecular characterization to clinical applications. Cancers. 2019 Oct 2;11(10):1483.
dc.identifier.issn2072-6694
dc.identifier.urihttps://hdl.handle.net/11351/5128
dc.descriptionBromodomini i domini extra terminal; BRD2; BRD4
dc.description.sponsorshipG.R. acknowledges supports from Fondo de Investigación Sanitaria PI15/00102 and PI18/01383, European Regional Development Fund (ERDF) “Una manera de hacer Europa”.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesCancers;11(10)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectHematologia oncològica
dc.subjectMedicaments proteínics
dc.subjectFarmacologia molecular
dc.subject.meshHematologic Neoplasms
dc.subject.mesh/drug therapy
dc.subject.meshProtein Domains
dc.subject.mesh/drug effects
dc.subject.meshMolecular Targeted Therapy
dc.titlePharmacological targeting of BET bromodomain proteins in acute myeloid leukemia and malignant lymphomas: from molecular characterization to clinical applications
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/cancers11101483
dc.subject.decsneoplasias hematológicas
dc.subject.decs/tratamiento farmacológico
dc.subject.decsdominios proteicos
dc.subject.decs/efectos de los fármacos
dc.subject.decsterapia molecular selectiva
dc.relation.publishversionhttps://www.mdpi.com/2072-6694/11/10/1483
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Reyes-Garau D, Roué G] Laboratori d’Hematologia Experimental, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Ribeiro M] Laboratori d’Hematologia Experimental, , Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University Medical School, Braganca Paulista, Brazil
dc.identifier.pmid31581671
dc.identifier.wos000498826000080
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F00102
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2017-2020/PI18%2F01383
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple